Literature DB >> 11498746

Changes in autoimmune thyroid disease following allogeneic bone marrow transplantation.

W Y Lee1, E S Oh, C K Min, D W Kim, J W Lee, M I Kang, W S Min, B Y Cha, K W Lee, H Y Son, S K Kang, C C Kim.   

Abstract

Autoimmune diseases can be transmitted and eliminated by bone marrow transplantation (BMT). There have been several cases of autoimmune thyroid disease (AITD) occurring after BMT, but AITD remission has been rarely reported. We present four cases in which the remission or transfer of AITD occurred after an allogeneic BMT. Two patients with severe aplastic anemia (SAA) showed evidence of remission of Hashimoto's thyroiditis which they had before allogeneic BMT. One patient with SAA, which developed during treatment with propylthiouracil for Graves' disease, underwent allogeneic BMT and showed evidence of Graves' disease remission following BMT. In one patient, new AITD occurred after an allogeneic BMT from an HLA-matched sibling who already had AITD. These cases support the evidence that the immune system is newly reconstituted after BMT, and severe autoimmune disease can be an indication for BMT. To fully understand the real changes in autoimmune status after BMT, long-term prospective studies are necessary.

Entities:  

Mesh:

Year:  2001        PMID: 11498746     DOI: 10.1038/sj.bmt.1703102

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Passenger Lymphocyte Syndrome and Autoimmune Hypothyroidism Following Hematopoietic Stem Cell Transplantation.

Authors:  Denis F Noubouossie; Mohammed I A Zaanona; Luciano J Costa; Huy P Pham; Marisa B Marques; Antonio Di Stasi
Journal:  Case Reports Immunol       Date:  2022-06-23

2.  Autoimmune thyroid disease following hematopoietic stem cell transplantation in childhood cancer survivors.

Authors:  Shunsuke Shimazaki; Itsuro Kazukawa; Masanori Minagawa
Journal:  Clin Pediatr Endocrinol       Date:  2021-12-16

3.  Graves' orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia - side effect of alemtuzumab therapy?

Authors:  Luminita Nicoleta Cima; Ioana Maria Lambrescu; Lavinia Stejereanu; Anca Colita; Reuven Or; Simona Fica
Journal:  Clin Case Rep       Date:  2018-03-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.